Russell Investments Group Ltd. Acquires 81,474 Shares of LifeStance Health Group, Inc. $LFST

Key Points

• Russell Investments Group Ltd. significantly increased its position in LifeStance Health Group by 16,459.4%, owning 81,969 shares worth $546,000 after purchasing an additional 81,474 shares in Q1.
• Major shareholder Summit Partners L. P. sold over 8.4 million shares of the company for approximately $42.6 million, reducing their ownership by 20.05%.
• LifeStance Health Group's recent earnings report showed a slight profit of ($0.01) per share, beating estimates and indicating a 10.6% increase in revenue compared to the previous year.

Russell Investments Group Ltd. grew its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 16,459.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 81,969 shares of the company's stock after purchasing an additional 81,474 shares during the period. Russell Investments Group Ltd.'s holdings in LifeStance Health Group were worth $546,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in LFST. Choreo LLC lifted its holdings in shares of LifeStance Health Group by 6.4% during the 1st quarter. Choreo LLC now owns 27,420 shares of the company's stock worth $183,000 after acquiring an additional 1,661 shares during the last quarter. Invesco Ltd. lifted its holdings in shares of LifeStance Health Group by 1.4% during the 1st quarter. Invesco Ltd. now owns 164,384 shares of the company's stock worth $1,095,000 after acquiring an additional 2,238 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of LifeStance Health Group by 2.4% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 138,781 shares of the company's stock worth $1,023,000 after acquiring an additional 3,305 shares during the last quarter. DekaBank Deutsche Girozentrale bought a new stake in shares of LifeStance Health Group during the 1st quarter worth $31,000. Finally, MetLife Investment Management LLC lifted its holdings in shares of LifeStance Health Group by 6.8% during the 4th quarter. MetLife Investment Management LLC now owns 85,914 shares of the company's stock worth $633,000 after acquiring an additional 5,492 shares during the last quarter. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, major shareholder Summit Partners L. P sold 8,407,643 shares of the stock in a transaction dated Monday, August 18th. The shares were sold at an average price of $5.07, for a total value of $42,626,750.01. Following the completion of the transaction, the insider directly owned 33,524,715 shares of the company's stock, valued at $169,970,305.05. This represents a 20.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Silversmith Partners I. Gp, Llc sold 3,592,357 shares of the company's stock in a transaction dated Monday, August 18th. The stock was sold at an average price of $5.07, for a total transaction of $18,213,249.99. Following the completion of the sale, the insider owned 14,324,197 shares in the company, valued at approximately $72,623,678.79. This trade represents a 20.05% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 20,407,643 shares of company stock valued at $103,466,750 over the last three months. Corporate insiders own 3.20% of the company's stock.

LifeStance Health Group Trading Down 1.8%

LifeStance Health Group stock traded down $0.10 during mid-day trading on Friday, hitting $5.37. The company's stock had a trading volume of 1,075,763 shares, compared to its average volume of 2,961,235. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.48 and a quick ratio of 1.48. The stock has a market cap of $2.09 billion, a price-to-earnings ratio of -107.40 and a beta of 1.17. The business has a 50 day moving average price of $4.77 and a 200-day moving average price of $5.83. LifeStance Health Group, Inc. has a 12 month low of $3.74 and a 12 month high of $8.61.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.03) by $0.02. The firm had revenue of $345.31 million during the quarter, compared to the consensus estimate of $345.05 million. LifeStance Health Group had a negative net margin of 1.23% and a negative return on equity of 1.11%. The company's quarterly revenue was up 10.6% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.06) earnings per share. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, analysts forecast that LifeStance Health Group, Inc. will post -0.18 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. UBS Group lifted their price objective on shares of LifeStance Health Group from $8.50 to $9.00 and gave the stock a "buy" rating in a report on Friday, August 8th. Wall Street Zen raised shares of LifeStance Health Group from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. Finally, BTIG Research initiated coverage on shares of LifeStance Health Group in a research note on Friday, July 25th. They issued a "buy" rating and a $8.00 price target for the company. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, LifeStance Health Group has a consensus rating of "Moderate Buy" and a consensus price target of $8.50.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.